Mativ Holdings, Inc. (NYSE:MATV - Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,020,000 shares, a decline of 65.9% from the March 15th total of 2,990,000 shares. Based on an average trading volume of 1,090,000 shares, the days-to-cover ratio is currently 0.9 days. Approximately 1.9% of the shares of the company are sold short.
Mativ Price Performance
NYSE:MATV traded down $0.03 during trading hours on Friday, reaching $4.59. 591,954 shares of the company were exchanged, compared to its average volume of 573,188. The business has a 50 day moving average of $6.36 and a 200 day moving average of $10.37. Mativ has a 1-year low of $4.34 and a 1-year high of $19.96. The company has a debt-to-equity ratio of 1.28, a current ratio of 2.40 and a quick ratio of 1.29. The company has a market capitalization of $250.02 million, a P/E ratio of -5.10, a P/E/G ratio of 1.08 and a beta of 0.68.
Mativ (NYSE:MATV - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.17). The company had revenue of $458.60 million for the quarter, compared to analyst estimates of $472.70 million. Mativ had a positive return on equity of 3.86% and a negative net margin of 2.46%. Research analysts forecast that Mativ will post 1.15 EPS for the current year.
Mativ Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 28th. Stockholders of record on Friday, March 14th were issued a dividend of $0.10 per share. The ex-dividend date was Friday, March 14th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 8.72%. Mativ's dividend payout ratio (DPR) is currently -44.44%.
Wall Street Analysts Forecast Growth
Separately, Stifel Nicolaus raised shares of Mativ from a "hold" rating to a "buy" rating and lowered their price target for the stock from $15.50 to $10.00 in a research report on Monday, March 24th.
View Our Latest Stock Report on MATV
Institutional Trading of Mativ
Several large investors have recently bought and sold shares of MATV. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Mativ by 3.8% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,724 shares of the company's stock valued at $335,000 after acquiring an additional 1,121 shares in the last quarter. Illinois Municipal Retirement Fund grew its holdings in Mativ by 5.2% during the 4th quarter. Illinois Municipal Retirement Fund now owns 32,258 shares of the company's stock worth $352,000 after acquiring an additional 1,583 shares during the last quarter. Rhumbline Advisers grew its holdings in Mativ by 1.0% during the 4th quarter. Rhumbline Advisers now owns 169,976 shares of the company's stock worth $1,853,000 after acquiring an additional 1,649 shares during the last quarter. MetLife Investment Management LLC raised its stake in shares of Mativ by 5.7% during the fourth quarter. MetLife Investment Management LLC now owns 33,153 shares of the company's stock valued at $361,000 after acquiring an additional 1,779 shares during the last quarter. Finally, KBC Group NV lifted its holdings in shares of Mativ by 93.2% during the fourth quarter. KBC Group NV now owns 4,787 shares of the company's stock worth $52,000 after purchasing an additional 2,309 shares during the period. 94.95% of the stock is owned by institutional investors and hedge funds.
Mativ Company Profile
(
Get Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Further Reading
Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.